Novel Insight into the Agonistic Mechanism of Alefacept In Vivo: Differentially Expressed Genes May Serve as Biomarkers of Response in Psoriasis Patients-Reference-Cited by-同舟云学术

Novel Insight into the Agonistic Mechanism of Alefacept In Vivo: Differentially Expressed Genes May Serve as Biomarkers of Response in Psoriasis Patients

Published:2007-05-18 Issue:11 Volume:178 Page:7442-7449
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Haider Asifa S.,Lowes Michelle A.,Gardner Humphrey,Bandaru Raj,Darabi Kamruz,Chamian Francesca,Kikuchi Toyoko,Gilleaudeau Patricia,Whalen Mary S.,Cardinale Irma,Novitskaya Inna,Krueger James G.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference26 articles.

1. A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis

2. Treatment of Chronic Plaque Psoriasis by Selective Targeting of Memory Effector T Lymphocytes

3. Cd2 Sets Quantitative Thresholds in T Cell Activation

4. Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes;JCI Insight;2023-11-08

2. The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis;Journal of Clinical Medicine;2023-10-17

3. Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro;American Journal of Transplantation;2023-10

4. Classification of human chronic inflammatory skin disease based on single-cell immune profiling;Science Immunology;2022-04-15

5. A transcriptome-wide association study identifies novel susceptibility genes for psoriasis;Human Molecular Genetics;2021-08-18